Work

O13-2 Raludotatug deruxtecan (R-DXd; DS-6000) in Japanese patients with ovarian cancer: subgroup analysis of a phase 1 study

Year: 2024

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.07.650

Authors: K. Sudo, E.P. Hamilton, K. Harano, S. Kitano, K. Takehara, A. Philipovskiy, B. Rini, D.R. Spigel, J. Lin, Y. Okuda, A. Bensmaine, Y. Myobatake, K. Moore

Institutions: National Cancer Center Hospital, Sarah Cannon, National Cancer Center Hospital East, Japanese Foundation For Cancer Research, National Hospital Organization, Shikoku Cancer Center, Florida Cancer Specialists & Research Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Daiichi Sankyo (United States), Daiichi-Sankyo (Japan), University of Oklahoma

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Daiichi-Sankyo, Daiichi Sankyo Europe

OpenAlex ID: W4403797749

FWCI: 0.327

Cites:

Cited by: 1

Related to: 10